Try our Advanced Search for more refined results
In Re: Zofran (Ondansetron)Products Liability Litigation
Case Number:
1:15-md-02657
Court:
Nature of Suit:
Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability
Multi Party Litigation:
Multi-district Litigation
Judge:
Firms
- Saunders & Walker
- Searcy Denney
- Seeger Weiss
- O'Leary Shelton
- Holland & Hart
- Edwards & Culver
- Phillips Lytle
- Wagstaff Law Firm
- Langdon & Emison
- Ventura Law (Danbury, CT)
- Peiffer Wolf
- Parker Waichman
- The Myers Firm
- Silva & Silva PA
- Paul Knopf
- Maynard Nexsen
- Hissey Mulderig
- Ashcraft & Gerel
- Snow Legal Group
- Gathings Law
- Maher Law Firm
- The Flood Law Firm
- Levin Simes
- Goldman Scarlato
- Silva & Silva
- Kershaw Talley
- Meyers & Flowers
- Reiner Slaughter
- Harness IP
- Cohen & Malad
- Pogust Goodhead
- Lear Werts
- Ware Jackson Lee
- Dunn Sheehan
- Donnelly Conroy
- Murray Law Firm
- Skikos Crawford
- Gurfein Douglas
- Nabers Law Firm
- Bailey & Greer
- Curtis Law Group
- Zoll & Kranz
- Baron & Budd
- Harrelson Law Firm
- Rheingold Giuffra
- Beasley Allen
- Heninger Garrison
- Bednarz & Bednarz
- Belt & Bruner
- Williams & Connolly
- Bernstein Liebhard
- Helland Law Firm
- Kiernan Trebach
- Helmsdale Law LLP
- Herman Herman & Katz
- Bird Law Group
- Justinian & Associates
- Power Rogers
- Cowper Law
- Lieff Cabraser
- Motley Rice
- Jackson & Tucker
- Bisnar Chase
- DiCello Levitt
- Bizer & DeReus
- Becker Law Office
- Nixon Peabody
- Tucker Ellis
- Pittman Dutton
- Engstrom Lipscomb
- Anapol Weiss
- Smith Porsborg
- Schlesinger Law Offices
- Feldman Shepherd
- Reich & Binstock
- BrownGreer PLC
- Michael Brady Lynch Firm
- Remer & Georges-Pierre
- Flint Cooper
- Napoli Shkolnik
- Robins Kaplan
- TorHoerman Law
- Sherman Silverstein
- Dowdy Cockerham
- eDiscovery CoCounsel
- Arnold & Porter
- Simmons Hanly
- Quattlebaum Grooms
- OnderLaw
- Eichen Crutchlow
- Morrow Morrow
- Thomas & Libowitz
- Blizzard Greenberg
- Brisbee & Stockton
- Rudolph Friedmann
- Bruera Law Firm
- Wagstaff & Cartmell
- Buxbaum Daue
- Kreindler & Kreindler
- Kelley Uustal
- Van Wey Presby
- Greenberg Traurig
- Shook Hardy
- Irwin Fritchie
- Junell & Associates
- Kagan Law Firm
- Kelley & Ferraro
- Kenny & Kenny
- George & Farinas
- Hare Wynn
- Ashley Injury Lawyers
- O'Hara Law Firm
- Jenner Law
- Goede DeBoest
- Grant & Eisenhofer
- Haug Partners
- Law Offices of Arnold E. DiJoseph
Companies
Sectors & Industries:
-
January 18, 2018
GSK Says Families Too Late To Amend Zofran MDL
GlaxoSmithKline attorneys on Thursday blasted an attempt by hundreds of families who blame the company's widely prescribed antiemetic for unexpected birth defects to amend their lawsuits and loop in federal investigative materials produced during a year of discovery.
-
November 06, 2017
Families Want Zofran MDL Paused To Beef Up Suit
Families suing GlaxoSmithKline for allegedly marketing to pregnant women a nausea treatment linked to birth defects urged a Massachusetts federal judge Friday to pause a dismissal bid while they file an amended complaint reflecting more than 1 million pages of documents produced in the fourth phase of discovery.
-
August 25, 2017
Foreign Discovery Mostly Denied In Zofran Birth Defect MDL
A Massachusetts federal judge on Thursday mostly rejected efforts by families suing GlaxoSmithKline over alleged links between birth defects and anti-nausea drug Zofran to get access to foreign regulatory files.
-
July 28, 2017
Families In Zofran MDL Seek Docs About Foreign Regulators
Families suing GlaxoSmithKline over its alleged misrepresentations about links between its anti-nausea drug Zofran and birth defects asked a federal court overseeing the multidistrict litigation on Thursday to make the company turn over regulatory files from Japan, the United Kingdom and Canada.
-
May 08, 2017
GSK Seeks To Strike Fraud Claims In Zofran MDL
GlaxoSmithKline PLC on Monday asked a Massachusetts federal court to strike fraud-based claims about its marketing of anti-nausea drug Zofran from multidistrict litigation alleging that the drug is linked to birth defects, saying that it will be prejudiced if consumers are allowed to obtain discovery on those claims.
-
April 24, 2017
Judge Keeps Fraud Claims Against GSK Alive In Zofran MDL
A Massachusetts federal judge on Monday declined to nix fraud-based claims from multidistrict litigation alleging that GlaxoSmithKline PLC's anti-nausea drug Zofran is linked to birth defects, saying that claims about the drug's labeling are sufficiently specific to pass muster even though he found the suit's marketing-campaign allegations too broad.
-
January 26, 2017
GSK Says No Basis For Fraud Claims In Zofran MDL
GlaxoSmithKline plc asked a Massachusetts federal judge on Thursday to dismiss fraud-based claims from multidistrict litigation connecting the anti-nausea drug Zofran to birth defects, arguing that the master complaint is devoid of details about any alleged lies and obfuscations.
-
January 04, 2017
Families Hit Back At GSK'S Zofran Fraud Dismissal Bid
Plaintiffs in a multidistrict litigation against GlaxoSmithKline PLC told a Massachusetts federal court Tuesday that they adequately set out off-label fraud claims in master complaints linking the anti-nausea drug Zofran to birth defects.
-
November 10, 2016
Judge Will Hear GSK's Arguments To Dismiss Zofran MDL
A Boston federal judge said Thursday that he would hear GlaxoSmithKline's arguments on dismissing some cases and claims from multidistrict litigation linking the anti-nausea drug Zofran to birth defects, overruling the objections of the plaintiffs.
-
October 14, 2016
GSK Wants Fraud Claims Dismissed In Zofran MDL
GlaxoSmithKline PLC on Thursday told a Massachusetts federal court that it shouldn't have to face fraud claims in multidistrict litigation over an alleged off-label marketing scheme for its anti-nausea drug Zofran, because the suits don't sufficiently outline the details of the alleged misconduct.